Sotera Health (NASDAQ:SHC) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Shares of Sotera Health (NASDAQ:SHC - Get Free Report) have been given an average recommendation of "Moderate Buy" by the seven brokerages that are currently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $16.08.

Several analysts recently issued reports on the stock. Citigroup boosted their target price on shares of Sotera Health from $18.00 to $20.00 and gave the company a "buy" rating in a research report on Wednesday, November 6th. Royal Bank of Canada reissued an "outperform" rating and issued a $17.00 price target on shares of Sotera Health in a report on Thursday, November 21st. Finally, The Goldman Sachs Group assumed coverage on Sotera Health in a report on Friday, December 6th. They issued a "neutral" rating and a $14.00 target price on the stock.

Institutional Trading of Sotera Health

A number of institutional investors have recently bought and sold shares of the stock. Darsana Capital Partners LP lifted its stake in Sotera Health by 716.9% in the third quarter. Darsana Capital Partners LP now owns 20,010,000 shares of the company's stock worth $334,167,000 after purchasing an additional 17,560,636 shares during the last quarter. Sessa Capital IM L.P. lifted its stake in shares of Sotera Health by 46.5% during the 3rd quarter. Sessa Capital IM L.P. now owns 6,300,597 shares of the company's stock worth $105,220,000 after acquiring an additional 2,000,000 shares during the last quarter. State Street Corp lifted its stake in shares of Sotera Health by 18.5% during the 3rd quarter. State Street Corp now owns 4,126,806 shares of the company's stock worth $68,918,000 after acquiring an additional 644,236 shares during the last quarter. Maverick Capital Ltd. boosted its holdings in Sotera Health by 3.5% during the 3rd quarter. Maverick Capital Ltd. now owns 3,497,367 shares of the company's stock valued at $58,406,000 after acquiring an additional 118,353 shares during the period. Finally, Geode Capital Management LLC grew its position in Sotera Health by 19.4% in the 3rd quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company's stock valued at $46,026,000 after acquiring an additional 447,186 shares during the last quarter. 91.03% of the stock is currently owned by institutional investors.

Sotera Health Stock Performance

SHC stock traded up $0.01 on Friday, hitting $13.63. The company had a trading volume of 728,318 shares, compared to its average volume of 688,609. The stock has a market cap of $3.86 billion, a price-to-earnings ratio of 54.52 and a beta of 1.96. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. The stock's 50-day simple moving average is $14.01 and its 200 day simple moving average is $14.31. Sotera Health has a 12-month low of $10.71 and a 12-month high of $17.44.

Sotera Health (NASDAQ:SHC - Get Free Report) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $0.17 EPS for the quarter, missing analysts' consensus estimates of $0.18 by ($0.01). The firm had revenue of $285.47 million for the quarter, compared to analysts' expectations of $278.64 million. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The firm's revenue was up 8.5% compared to the same quarter last year. During the same quarter last year, the company posted $0.18 EPS. As a group, equities research analysts expect that Sotera Health will post 0.61 earnings per share for the current fiscal year.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.